You have 9 free searches left this month | to do more

isatuximab

Isatuximab is a drug used to treat Multiple Myeloma, AL Amyloidosis, Plasma Cell Myeloma, and other conditions. Isatuximab is being actively studied in 28 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
SanofiDana Farber Cancer InstituteBinod Dhakal
Intergroupe Francophone du MyelomeWashington University School of MedicineCraig Hofmeister
Poitiers University HospitalBeth Israel Deaconess Medical CenterDivaya Bhutani
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Recruiting
  • Multiple Myeloma
  • Stockholm, Sweden
    Karolinska Institutet
2021-11-29
Nov 29, 2021
C
Recruiting
  • Monoclonal Gammopathy
  • Isatuximab
  • New York, New York
  • +1 more
2021-11-23
Nov 23, 2021
W
Recruiting
  • Natural Killer/T-cell Lymphoma
  • +2 more
  • Seoul, Kangnamgu, Korea, Republic of
    Samsung Medical Center
2021-09-22
Sep 22, 2021
T
Not yet recruiting
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • Bendamustine Hydrochloride
  • Isatuximab
  • (no location specified)
2021-11-10
Nov 10, 2021
P
Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Isatuximab
  • +3 more
  • Poitiers, France
    CHU Poitiers
2021-11-25
Nov 25, 2021
O
Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Portland, Oregon
    OHSU Knight Cancer Institute
2021-12-22
Dec 22, 2021
M
Recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
2021-05-14
May 14, 2021
U
Not yet recruiting
  • Multiple Myeloma
  • Cancer
  • Isatuximab
  • +2 more
  • Chapel Hill, North Carolina
  • +2 more
2021-12-06
Dec 6, 2021
P
Recruiting
  • Multiple Myeloma
  • Myeloma
  • Isatuximab
  • +3 more
  • Poitiers, France
    CHU Poitiers
2021-11-03
Nov 3, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • Isatuximab
  • +3 more
  • Berlin, Germany
  • +18 more
2021-01-31
Jan 31, 2021
E
Recruiting
  • AL Amyloidosis
  • Orange, California
  • +5 more
2021-04-29
Apr 29, 2021
W
Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-03-31
Mar 31, 2021
W
Not yet recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-12-02
Dec 2, 2021
S
Active, not recruiting
  • Plasma Cell Myeloma
  • Isatuximab
  • Scottsdale, Arizona
  • +17 more
2021-09-24
Sep 24, 2021
J
Recruiting
  • Multiple Myeloma
  • +2 more
  • Isatuximab
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-07-20
Jul 20, 2021
M
Recruiting
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
2021-11-02
Nov 2, 2021
T
Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • San Francisco, California
  • +2 more
2021-07-14
Jul 14, 2021
U
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-09
Dec 9, 2021
C
Not yet recruiting
  • Multiple Myeloma
  • Isatuximab
  • +3 more
  • Aarhus, Denmark
  • +5 more
2021-11-05
Nov 5, 2021
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Cincinnati, Ohio
  • +56 more
2021-12-08
Dec 8, 2021